Log in to save to my catalogue

Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative stud...

Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative stud...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f1f9d55effd4cc5815d2a4924c107ec

Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model

About this item

Full title

Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model

Publisher

Cham: Springer International Publishing

Journal title

Journal of Patient-Reported Outcomes, 2021-08, Vol.5 (1), p.75-75, Article 75

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Duchenne muscular dystrophy is a rare genetic neuromuscular disorder, which can result in early death due to disease progression. Ataluren is indicated for the treatment of nonsense mutation Duchenne muscular dystrophy, in ambulatory individuals aged two years and older. This study explored the symptoms and impacts of nonsense mutatio...

Alternative Titles

Full title

Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7f1f9d55effd4cc5815d2a4924c107ec

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f1f9d55effd4cc5815d2a4924c107ec

Other Identifiers

ISSN

2509-8020

E-ISSN

2509-8020

DOI

10.1186/s41687-021-00341-x

How to access this item